Robert Montal

3.8k total citations · 2 hit papers
19 papers, 2.2k citations indexed

About

Robert Montal is a scholar working on Oncology, Hepatology and Surgery. According to data from OpenAlex, Robert Montal has authored 19 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 7 papers in Hepatology and 5 papers in Surgery. Recurrent topics in Robert Montal's work include Hepatocellular Carcinoma Treatment and Prognosis (7 papers), Pancreatic and Hepatic Oncology Research (5 papers) and Cancer Genomics and Diagnostics (4 papers). Robert Montal is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (7 papers), Pancreatic and Hepatic Oncology Research (5 papers) and Cancer Genomics and Diagnostics (4 papers). Robert Montal collaborates with scholars based in Spain, United States and Australia. Robert Montal's co-authors include Josep M. Llovet, Daniela Sia, Richard S. Finn, Augusto Villanueva, Myron Schwartz, Marc Puigvehí, Edward Kim, Florian Castet, Philipp K. Haber and Michael Buckstein and has published in prestigious journals such as Gastroenterology, Clinical Cancer Research and International Journal of Molecular Sciences.

In The Last Decade

Robert Montal

18 papers receiving 2.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Molecular therapies and precision medicine for hepatocellular carcinoma

2018 1.4k citations Josep M. Llovet, Robert Montal et al. Nature Reviews Clinical Oncology profile →
Evidence-Based Management of Hepatocellular Carcinoma: Systematic Review and Meta-analysis of Randomized Controlled Trials (2002–2020)

2021 165 citations Philipp K. Haber, Marc Puigvehí et al. Gastroenterology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Robert Montal Spain	11	921	817	682	614	527	19	2.2k
Anna Saborowski Germany	19	711 0.8×	1.0k 1.3×	579 0.8×	770 1.3×	535 1.0×	57	2.5k
Paolo Abada United States	19	1.2k 1.3×	602 0.7×	538 0.8×	652 1.1×	374 0.7×	63	2.3k
Sara Toffanin United States	14	890 1.0×	1.2k 1.4×	793 1.2×	515 0.8×	266 0.5×	18	2.3k
Ao Huang China	21	572 0.6×	725 0.9×	787 1.2×	574 0.9×	479 0.9×	51	1.9k
Philippa Newell United States	11	1.2k 1.4×	1.5k 1.9×	916 1.3×	902 1.5×	557 1.1×	16	3.3k
Johann von Felden Germany	19	769 0.8×	679 0.8×	658 1.0×	456 0.7×	304 0.6×	44	1.9k
Roberta Pang Hong Kong	29	815 0.9×	1.6k 1.9×	987 1.4×	1.1k 1.7×	288 0.5×	53	3.0k
Clara Alsinet Spain	18	727 0.8×	1.7k 2.1×	841 1.2×	462 0.8×	263 0.5×	27	2.7k
Shao-Chun Chang United States	7	676 0.7×	637 0.8×	349 0.5×	1.2k 1.9×	448 0.9×	7	2.2k
Lila Adnane United States	6	659 0.7×	1.1k 1.4×	440 0.6×	1.0k 1.7×	582 1.1×	7	2.6k

Countries citing papers authored by Robert Montal

Since Specialization

Citations

This map shows the geographic impact of Robert Montal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Montal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Montal more than expected).

Fields of papers citing papers by Robert Montal

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Montal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Montal. The network helps show where Robert Montal may publish in the future.

Co-authorship network of co-authors of Robert Montal

This figure shows the co-authorship network connecting the top 25 collaborators of Robert Montal. A scholar is included among the top collaborators of Robert Montal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert Montal. Robert Montal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Sorolla, Maria Alba, Eva Parisi, Anabel Sorolla, et al.. (2025). Comprehensive immunophenotyping of gastric adenocarcinoma identifies an inflamed class of tumors amenable to immunotherapies. Journal for ImmunoTherapy of Cancer. 13(3). e010024–e010024. 2 indexed citations

Prieto, Ana I., Ester Vilaprinyó, Marta Bonet, et al.. (2024). Surrogate endpoints in phase III randomized trials of advanced gastroesophageal cancer: A systematic review and meta-analysis. Critical Reviews in Oncology/Hematology. 201. 104416–104416. 1 indexed citations

Sorolla, Maria Alba, Eva Parisi, Anabel Sorolla, et al.. (2023). PD-2 Comprehensive immunophenotyping of gastric adenocarcinoma identifies an inflamed class of tumors amenable to immunotherapies. Annals of Oncology. 34. S1–S1.

Soler, Marta, Verónica Dávalos, Carlos A. García‐Prieto, et al.. (2023). Epigenetic inactivation of the 5-methylcytosine RNA methyltransferase NSUN7 is associated with clinical outcome and therapeutic vulnerability in liver cancer. Molecular Cancer. 22(1). 83–83. 38 indexed citations

Parisi, Eva, Robert Montal, Anabel Sorolla, et al.. (2023). PLA2G12A as a Novel Biomarker for Colorectal Cancer with Prognostic Relevance. International Journal of Molecular Sciences. 24(13). 10889–10889. 3 indexed citations

Taberna, Miren, Marc Oliva, Robert Montal, et al.. (2021). The potential role of imaging techniques in avoiding neck dissection during salvage surgery after head and neck carcinoma treated with bioradiotherapy. The Journal of Laryngology & Otology. 135(11). 970–975. 1 indexed citations

Haber, Philipp K., Marc Puigvehí, Florian Castet, et al.. (2021). Evidence-Based Management of Hepatocellular Carcinoma: Systematic Review and Meta-analysis of Randomized Controlled Trials (2002–2020). Gastroenterology. 161(3). 879–898. 165 indexed citations breakdown →

Sorolla, Maria Alba, et al.. (2021). Microenvironmental Reactive Oxygen Species in Colorectal Cancer: Involved Processes and Therapeutic Opportunities. Cancers. 13(20). 5037–5037. 42 indexed citations

Bassaganyas, Laia, Roser Pinyol, Roger Esteban-Fabró, et al.. (2020). Copy-Number Alteration Burden Differentially Impacts Immune Profiles and Molecular Features of Hepatocellular Carcinoma. Clinical Cancer Research. 26(23). 6350–6361. 40 indexed citations

10.

Parisi, Eva, et al.. (2020). Prognostic Factors Involved in the Epithelial–Mesenchymal Transition Process in Colorectal Cancer Have a Preponderant Role in Oxidative Stress: A Systematic Review and Meta-Analysis. Cancers. 12(11). 3330–3330. 7 indexed citations

11.

Llovet, Josep M., Robert Montal, & Augusto Villanueva. (2019). Randomized trials and endpoints in advanced HCC: Role of PFS as a surrogate of survival. Journal of Hepatology. 70(6). 1262–1277. 145 indexed citations

12.

Montal, Robert, Carmen Andreu-Oller, Laia Bassaganyas, et al.. (2019). Molecular portrait of high alpha-fetoprotein in hepatocellular carcinoma: implications for biomarker-driven clinical trials. British Journal of Cancer. 121(4). 340–343. 63 indexed citations

13.

Montironi, Carla, Robert Montal, & Josep M. Llovet. (2019). New Drugs Effective in the Systemic Treatment of Hepatocellular Carcinoma. Clinical Liver Disease. 14(2). 56–61. 16 indexed citations

14.

Llovet, Josep M., Robert Montal, Daniela Sia, & Richard S. Finn. (2018). Molecular therapies and precision medicine for hepatocellular carcinoma. Nature Reviews Clinical Oncology. 15(10). 599–616. 1392 indexed citations breakdown →

15.

Moeini, Agrin, Daniela Sia, Zhongyang Zhang, et al.. (2017). Mixed hepatocellular cholangiocarcinoma tumors: Cholangiolocellular carcinoma is a distinct molecular entity. Journal of Hepatology. 66(5). 952–961. 113 indexed citations

16.

Lencioni, Riccardo, Robert Montal, Ferràn Torres, et al.. (2017). Objective response by mRECIST as a predictor and potential surrogate end-point of overall survival in advanced HCC. Journal of Hepatology. 66(6). 1166–1172. 153 indexed citations

17.

Azuara, Daniel, Cristina Santos, Adriana López‐Doriga, et al.. (2016). Nanofluidic Digital PCR and Extended Genotyping of RAS and BRAF for Improved Selection of Metastatic Colorectal Cancer Patients for Anti-EGFR Therapies. Molecular Cancer Therapeutics. 15(5). 1106–1112. 12 indexed citations

18.

Montal, Robert, Marc Oliva, Miren Taberna, et al.. (2016). Residual neck disease management in squamous-cell carcinoma of the head and neck treated with radiotherapy plus cetuximab. Clinical & Translational Oncology. 18(11). 1140–1146. 3 indexed citations

19.

Oliva, Marc, Miren Taberna, Robert Montal, et al.. (2016). Salvage surgery after head and neck squamous cell carcinoma treated with bioradiotherapy. Head & Neck. 39(1). 116–121. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact